- Home
- SDRL vs BCRX Comparison
SDRL vs BCRX Comparison
Compare SDRL & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDRL | BCRX |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SDRL | BCRX |
|---|---|---|
| Price | $47.97 | $9.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $56.00 | $20.82 |
| AVG Volume (30 Days) | 690.6K | ★ 3.3M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.61 | ★ 381.40 |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,437,000,000.00 | $25,186,000.00 |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $16.68 | $12.55 |
| P/E Ratio | $130.58 | ★ N/A |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $28.10 | $6.00 |
| 52 Week High | $55.47 | $11.22 |
Technical Indicators
Market Signals| Indicator | SDRL | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 50.66 |
| Support Level | $46.78 | $8.79 |
| Resistance Level | $49.61 | $10.01 |
| Average True Range (ATR) | 1.83 | 0.49 |
| MACD | 0.53 | 0.07 |
| Stochastic Oscillator | 92.26 | 45.05 |
Price Performance
Historical ComparisonAbout SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.